Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.795
-0.355 (-6.89%)
Mar 9, 2026, 3:58 PM EDT - Market open
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$305,370
Profits / Employee
-$135,519
Market Cap
448.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| Castle Biosciences | 883 |
| CareDx | 765 |
| Burning Rock Biotech | 674 |
| Biodesix | 334 |
| MDxHealth | 312 |
MYGN News
- 13 days ago - Myriad Genetics Beats Q4 Expectations, Shares Surge Amid Core Franchise Growth - Seeking Alpha
- 13 days ago - Myriad Genetics, Inc. (MYGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution - GlobeNewsWire
- 18 days ago - FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test - GlobeNewsWire
- 20 days ago - Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026 - GlobeNewsWire
- 7 weeks ago - Myriad Genetics, Inc. (MYGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance - GlobeNewsWire
- 2 months ago - Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire